The merger of medicine and growth mindset.
Bionature E.A. Ltd, established in 2003, is a spin-off of the University of Crete in Greece. The Company's founders are Professors Elias Castanas and Achilleas Gravanis, both of the University of Crete Medical School. Bionature's stakeholders also include the private investment group of Emergo and the University of Crete.
The Faculty of Medicine of the University of Crete was established in 1984 and is presently ranked among the best medical schools in Europe. Emergo is a diversified investment group with a long-term vision. Their ownership structure allows them to think outside of the box while respecting the mission and integrity of management and make short-track decisions that are aligned with the long-term strategies of portfolio companies.
Chairman
Alfred Balm
Chairman, the Emergo Group of CompaniesBoard of Directors
Mike Balm
Director, the Emergo Group of CompaniesElias Castanas
Emeritus Professor of Experimental Endocrinology, Medical School University of CreteAchilleas Gravanis
Professor of Pharmacology, Medical School University of CreteResearcher Institute of Molecular Biology & Biotechnology, Foundation of Research & Technology-Hellas
Affiliated Research Professor Center of Drug Discovery Northeastern University
Nicolaos Chaniotakis
Professor of Chemistry, Dept of Chemistry University of CreteScientific Advisory Board
George Chrousos
Ex-Chief of Branch, NICHD, NIHEmeritus Professor of Pediatrics, Medical School University of Athens
Demitrios Vavvas
Associate Professor of Ophthalmology, Harvard Medical SchoolRobin J Franklin
Professor of Stem Cell Medicine, Stem Cell Institute, Cambridge UniversityAlexandros Makriyannis
Director Center Drug DiscoveryProfessor of Chemical Biology, Bouve School of Pharmacy, Northeastern University
Francis LeBlanc
Professor Emeritus, Clinical Neurosciences, University of CalgaryResearch Partners
Theodora Calogeropoulou
Research DirectorInstitute Chemical Biology , National Hellenic Research Foundation
(design and organic synthesis of microneurotrophins)
Ioannis Charalampopoulos
Associate Professor of Pharmacology, Medical School University of CreteResearcher Institute of Molecular Biology & Biotechnology, Foundation of Research & Technology-Hellas
(pharmacology of microneurotrohins in cells and animal models of Alzheimer disease)
Demitrios Tzeranis
Lecturer of Bioengineering, University of Cyprus(microneurotrophins in bioengineered 3D cultures of human neural stem cells and neurons)
Collaborators
Christina Dalla
Associate Professor of Pharmacology, Medical School University of Athens(behavioural pharmacology of microneurotrophins)
Nicolaos Pitsikas
Professor of Pharmacology, Medical School University of Thessaly(behavioural pharmacology of microneurotrophins)
Domna Karagogeos
Professor of Developmental Neurobiology, Medical School University of Crete(microneurotrophins and demyelination-remyelination)
Kyriaki Thermos
Professor of Pharmacology, Medical School University of Crete(eye neuropharmacology of microneurotrophins)
Fevronia Angelatou
Professor of Physiology, Dept. of Biology University of Patras(microneurotrophins in Parkinson disease)
Research & Development
Our research focuses on science related to the neurobiology and neurophysiology of neurodegenerative processes. We implement state of the art technologies, such as reverse genomics, advanced imaging, human disease specific transgenic animals, neural stem cell biology.
Our research process Publications